Goal: To analyze and apply critical thinking skills in the pharmacokinetics and pharmacodynamics of psychopharmacological agents for patient treatment and health promotion while applying evidence-based research.
|Chapter 8, Case 2||Fiona is a 29-year-old woman who works in a medical factory making medical equipment. She lives with her husband and in-laws. Over the last week, she has been more isolative, saying strange things to her husband, and not sleeping due to unidentified fearfulness. The only stressor that her husband can identify is that they started talking about having children. Fiona refuses to do her ADLs, eats very little, and appears intermittently in a trancelike state. The family was becoming more and more concerned and attempted to get Fiona to see their family doctor, but she was refusing. Finally, police were called due to worsening regressed behavior and Fiona was brought to the local emergency department (ED) for evaluation. The ED physician examined her and reported after labs and neuroimaging that she was medically stable. Although the patient reported no history of psychiatric illness, she did report that her maternal grandmother was in a state hospital for most of her life. The physician recommended psychiatric hospitalization for new onset of a psychotic illness.|
|Questions:||Remember to answer these questions from your textbooks and clinical guidelines to create your evidence-based treatment plan. At all times, explain your answers.
YOUR RESPONSE MAY BE DIFFERENT THAN THE DIAGNOSIS AND TREATMENT FOUND IN YOUR TEXTBOOK.
- Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources.
Requirements: 500 words
The most recommended non-pharmacological approach for treating schizophrenia is cognitive behavioral therapy (CBT). It effectively modifies the patient’s beliefs and behaviors, leading to negative emotions (Laws et al., 2018). The model mainly has two parts, including a cognitive component and a behavioral component. The cognitive component focuses on helping a person to change their thinking about the situation. On the other hand, the behavioral component delves into helping the patient on changing her reactions. One risk associated with CBT is poor patient adherence. The patient is less likely to adhere to treatment, especially when a therapist does not conduct a thorough follow-up. One benefit of this approach is the cost-effective approach to treating patients with psychotic disorders. However, it is a costly treatment approach compared to a pharmacological approach. For instance, haloperidol costs from US $22.20 to $US 30.27 in 4 weeks of treatment. Another benefit of CBT is that it helps in improving the patient’s psychological functioning and thinking patterns.